LI-RADS v2018 major criteria: Do hepatocellular carcinomas in non-alcoholic steatohepatitis differ from those in virus-induced chronic liver disease on MRI?

Date publication

mars 2021

Journal

European journal of radiology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr HOEFFEL Christine

Tous les auteurs :
Barat M, Nguyen TTL, Hollande C, Coty JB, Hoeffel C, Terris B, Dohan A, Mallet V, Pol S, Soyer P

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/33740627

Résumé

LI-RADS v2018 diagnostic system is used to diagnose hepatocellular carcinoma (HCC) in at risk patients. However, its applicability to HCC in non-alcoholic steatohepatitis (NASH) has not been specifically studied. The purpose of this study was to assess the applicability of LI-RADS v2018 diagnostic system for HCC in patients with NASH.

Mots clés

Carcinoma, hepatocellular (Unique ID, D006528), Liver neoplasms (Unique ID, D008113), Magnetic resonance imaging (Unique ID, D008279), Non-alcoholic fatty liver disease (Unique ID, D065626)

Référence

Eur J Radiol. 2021 Mar 11;138:109651